Recent STIM News
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:30:00 PM
- NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month • GlobeNewswire Inc. • 05/01/2024 12:31:00 PM
- Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call • GlobeNewswire Inc. • 04/23/2024 08:30:00 PM
- New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital • GlobeNewswire Inc. • 04/10/2024 12:31:00 PM
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/27/2024 08:30:00 PM
- NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression • GlobeNewswire Inc. • 03/25/2024 12:30:00 PM
- Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network • GlobeNewswire Inc. • 03/07/2024 01:22:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:01:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:31:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:30:31 PM
- Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results • GlobeNewswire Inc. • 03/05/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:02:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:02:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 10:02:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 09:10:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:02:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 09:48:41 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 09:16:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 10:33:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 10:21:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 09:54:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 09:23:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:02:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 09:14:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 08:19:18 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM